The Effects on Proliferation of siRNA-Mediated GLS1 Inhibition in MDA-MB 231 Breast Cancer Cells †
1
Genom and Stem Cell Center (GENKOK), Department of Medical Biology, Faculty of Medicine, Erciyes University, 38030 Kayseri, Turkey
2
Department of Medical Biology, Faculty of Medicine, Yüzüncü Yıl University, 65090 Van, Turkey
*
Author to whom correspondence should be addressed.
†
Presented at the 3rd International conference on Natural Products for Cancer Prevention and Therapy,
Kayseri, Turkey, 18–20 December 2019.
Proceedings 2019, 40(1), 25; https://doi.org/10.3390/proceedings2019040025
Published: 26 December 2019
(This article belongs to the Proceedings of The 3rd International conference on Natural Products for Cancer Prevention and Therapy)
Abstract
:The main energy source of cancer cells is known as glucose. However, they use glutamine as a second energy source besides glucose. In this study we investigated effect of siRNA mediated inhibition of glutaminase (GLS1) enzyme in the first step of glutamine metabolism on proliferation and apoptosis which are the main features of cancer. In our study we determined the cell viability by MTS analysis and the apoptosis rate by Annexin V using triple negative MDA-MB 231 cell line belonging to aggressive subtype of breast cancer. Our study demonstrated that siRNA-mediated silencing GLS1 reduced proliferation in this cancer cell line. It has been shown that inhibition of GLS1 significantly decreased cells, but there was no change in the rate of apoptosis. The cause of this decrease may be through a different pathway other than apoptosis. In this study we have shown that GLS1 inhibition does not induce apoptosis in this cell line, contrary to the literature, and activates the death pathway through a different pathway. We believe that interrupting the glutamine energy pathway for cancer cells will be promising approach for cancer treatment and further studies are needed for this.
Acknowledgments
This work supported by Erciyes University Scientific Research Fund (EU-BAP) Grand Number: TDK-2018-8166.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Akar, S.; Hamurcu, Z.; Donmez-Altuntas, H. The Effects on Proliferation of siRNA-Mediated GLS1 Inhibition in MDA-MB 231 Breast Cancer Cells. Proceedings 2019, 40, 25. https://doi.org/10.3390/proceedings2019040025
AMA Style
Akar S, Hamurcu Z, Donmez-Altuntas H. The Effects on Proliferation of siRNA-Mediated GLS1 Inhibition in MDA-MB 231 Breast Cancer Cells. Proceedings. 2019; 40(1):25. https://doi.org/10.3390/proceedings2019040025
Chicago/Turabian StyleAkar, Sakine, Zuhal Hamurcu, and Hamiyet Donmez-Altuntas. 2019. "The Effects on Proliferation of siRNA-Mediated GLS1 Inhibition in MDA-MB 231 Breast Cancer Cells" Proceedings 40, no. 1: 25. https://doi.org/10.3390/proceedings2019040025
